These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9013748)

  • 21. Body composition in Cushing's disease.
    Lamberts SW; Birkenhäger JC
    J Clin Endocrinol Metab; 1976 May; 42(5):864-8. PubMed ID: 1270577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma concentrations of adipocyte fatty acid binding protein in patients with Cushing's syndrome.
    Ďurovcová V; Marek J; Hána V; Matoulek M; Zikán V; Haluzíková D; Kaválková P; Lacinová Z; Kršek M; Haluzík M
    Physiol Res; 2010; 59(6):963-971. PubMed ID: 20533865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate-specific antigen is increased in female patients with Cushing's disease.
    Manetti L; Lupi I; Bogazzi F; Pellegrini G; Precisi A; Grasso L; Nencetti C; Gasperi M; Martino E
    J Endocrinol Invest; 2002 Oct; 25(9):RC29-31. PubMed ID: 12398228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased lipolysis of subcutaneous abdominal adipose tissue and altered noradrenergic activity in patients with Cushing's syndrome: an in-vivo microdialysis study.
    Krsek M; Rosická M; Nedvídková J; Kvasnicková H; Hána V; Marek J; Haluzík M; Lai EW; Pacák K
    Physiol Res; 2006; 55(4):421-428. PubMed ID: 16238457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bedside assessment of skin-fold thickness. A useful measurement for distinguishing Cushing's disease from other causes of hirsutism and oligomenorrhea.
    Corenblum B; Kwan T; Gee S; Wong NC
    Arch Intern Med; 1994 Apr; 154(7):777-81. PubMed ID: 8147682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Leptin in the endocrinology of obesity].
    Sanz París A; Guallar Labrador AM; Albero Gamboa R
    An Med Interna; 1999 Oct; 16(10):530-40. PubMed ID: 10603674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose and free fatty acid turnover in Cushing's syndrome.
    Saunders J; Hall SE; Sönksen PH
    J Endocrinol Invest; 1980; 3(3):309-11. PubMed ID: 7430558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cushing's syndrome and serum calcium-albumin interaction.
    Leme CE; Wajchenberg BL; Leme PR; Cesar FP
    Horm Metab Res; 1977 Mar; 9(2):166. PubMed ID: 16819
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum levels of calcitonin in Cushing's syndrome.
    Luisetto G; Mantero F; Boscaro M; Tizian L; Zangari M; Ziliotto D
    J Endocrinol Invest; 1986 Jun; 9(3):239-41. PubMed ID: 3760462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucocorticoid Regulation of Food-Choice Behavior in Humans: Evidence from Cushing's Syndrome.
    Moeller SJ; Couto L; Cohen V; Lalazar Y; Makotkine I; Williams N; Yehuda R; Goldstein RZ; Geer EB
    Front Neurosci; 2016; 10():21. PubMed ID: 26903790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered circadian blood pressure rhythm in patients with Cushing's syndrome.
    Imai Y; Abe K; Sasaki S; Minami N; Nihei M; Munakata M; Murakami O; Matsue K; Sekino H; Miura Y
    Hypertension; 1988 Jul; 12(1):11-9. PubMed ID: 3397172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of creatinine clearance in patients with Cushing's syndrome.
    Hatton J; Parr MD; Blouin RA
    DICP; 1989 Dec; 23(12):974-7. PubMed ID: 2603451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypercoagulable state in Cushing's syndrome: a systematic review.
    Van Zaane B; Nur E; Squizzato A; Dekkers OM; Twickler MT; Fliers E; Gerdes VE; Büller HR; Brandjes DP
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2743-50. PubMed ID: 19454584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-related modifications of circadian rhythm of serum leptin in healthy men.
    Zhao ZY; Fu YR; Li XH; Li YY; Bogdan A; Touitou Y
    Gerontology; 2002; 48(5):309-14. PubMed ID: 12169797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship of mitochondrial dysfunction and the development of insulin resistance in Cushing's syndrome.
    Ježková J; Ďurovcová V; Wenchich L; Hansíková H; Zeman J; Hána V; Marek J; Lacinová Z; Haluzík M; Kršek M
    Diabetes Metab Syndr Obes; 2019; 12():1459-1471. PubMed ID: 31695455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diurnal rhythm in serum leptin.
    Wolthers OD; Heuck C; Skjaerbaek C
    J Pediatr Endocrinol Metab; 1999; 12(6):863-6. PubMed ID: 10614544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leptin: physiology and pathophysiology.
    Frühbeck G; Jebb SA; Prentice AM
    Clin Physiol; 1998 Sep; 18(5):399-419. PubMed ID: 9784936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Protein fractions in the blood serum in Itsenko-Cushing syndrome].
    SAMOKHVALOVA MA
    Probl Endokrinol Gormonoter; 1959; 5():46-51. PubMed ID: 14441234
    [No Abstract]   [Full Text] [Related]  

  • 39. [Recurrence of Cushing's syndrome in pregnancy].
    Levesque H; Gancel A; Ducarne-Avril C; Courtois H
    Presse Med; 1990 Apr; 19(16):763-4. PubMed ID: 2140165
    [No Abstract]   [Full Text] [Related]  

  • 40. Twenty-four-hour variation in serum leptin in the elderly.
    Franceschini R; Corsini G; Cataldi A; Fiorucci A; Tenerelli P; Rolandi E; Barreca T
    Metabolism; 1999 Aug; 48(8):1011-4. PubMed ID: 10459566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.